An investor analysis arguing that Lilly's two tirzepatide drugs still anchor its growth outlook. Details are on Seeking Alpha.
Recap by typeshit. Full story at Seeking Alpha.
BuzzFeed notes these medications have helped people worldwide, pro athletes among them, with weight, appetite and blood sugar control.
Novo Nordisk's weight loss drug brand is the presenting sponsor of the playoff game, airing at 4:30 PM ET on TSN, RDS and CFL+.
Novo Nordisk's Wegovy puts its name on the October 31 playoff game in Canada, airing at 4:30 PM ET on TSN, RDS and CFL+.
A doctor writes about a 45-year-old woman without diabetes who came in for obesity treatment, opening a column on how such patients are handled.
The study looks at an oral non-peptide GLP-1 drug in Japanese adults, a group researchers say is more prone to metabolic disease.
Martin cautions followers that peptides being simpler to obtain is no reason to use ones that haven't been tested much.
Loading…